Pipeline

TOPICAL MEK INHIBITOR PROGRAMS

ProgramPreclinicalPhase 1Phase 2Phase 3
Neurofibromatosis Type 1
Treatment of Cutaneous Neurofibromas
Squamous Cell Carcinoma
Prevention in High-Risk Transplant Recipients
Congenital Birthmarks
Non-surgical Treatment
ProgramStage
Neurofibromatosis Type 1tarTreatment of Cutaneous Neurofibromas Phase 2
Squamous Cell CarcinomaPrevention in High-Risk Transplant Recipients Preclinical
Congenital BirthmarksNon-surgical Treatment Preclinical